Tuesday, May 29, 2018 • 10:15 - 11:45
Track 4 - DRUGS IN THE ED
Track Chair: Dr. Jeffrey Eppler
Rom: TELUS Glen 203-204

Approach to the Bleeding Patient in the Emergency Department - It Always Stops - Dr. John Ward

Description: An approach to the bleeding patient in the ED with emphasis on agents such as tranexamic acid, DDAVP, Prothrombin complex and factor Xa and IIa inhibitors.

Learning Objectives:

  1. To understand the options available to manage the bleeding patient
  2. To know the indications for each of these agents.

Biography: Former hematologist and general internist. Clinical Professor, Department of Emergency Medicine, UBC.

Antimicrobial Stewardship in the Emergency Department - Dr. Edith Blondel-Hill

Description: My talk will focus on some of the major infectious syndromes seen in the ER and will emphasize the  antimicrobial stewardship approach to their management and treatment

Learning Objectives:

  1. Review sepsis guidelines based on antimicrobial resistance risk factors
  2. Review best antibiotic choices for skin and soft tissue infections
  3. Review the differential diagnosis and management of asymptomatic bacteriuria

Pearls:

  1. Not all sepsis requires piperacillin-tazobactam
  2. Cefazolin allergy is extremely rare
  3. Symptom Free Pee-Let It Be

Biography: Medical microbiologist/ Infectious diseases   Medical director of antimicrobial stewardship  Co-author Bugs and Drugs app

Update on Resuscitation Drugs New and Old - Dr. Jeffrey Eppler

Description: Resuscitation drugs… it can be so hard to make sense of the evidence. If there even is any. This talk will review uses of and evidence for some old medications like epinephrine, vasopressin and methylene blue as preview new, potentially game changing agents currently under investigation.

Learning Objectives:

  1. Improve understanding of the indications for a number of resuscitation drugs including epinephrine, vasopressin and methylene blue.
  2. Review the evidence (or lack thereof) for a number of commonly used resuscitation drugs.
  3. Review potentially practice changing resuscitation trials and medications under investigation.

Pearls:

  1. Much of the evidence around commonly used resuscitation agents such as epinephrine is weak or non-existent.
  2. Understanding resuscitation agents will help us use them more wisely and with greater effect.
  3. There may be new agents on the horizon that will have a major positive impact on resuscitation.

Biography: Full time emergency medicine practice in Kelowna, B.C. for more than 20 years. Interests include harm reduction and toxicology.